Next |
home / stock / ogen / ogen message board
Subject | By | Source | When |
---|---|---|---|
Maybe not. :) | retired early | investorshub | 03/01/2023 6:46:26 PM |
Don't madder they will short it down to nothing | Nathan123456 | investorshub | 12/22/2022 10:32:36 PM |
Surfs up. ::) | retired early | investorshub | 12/22/2022 2:35:47 PM |
Chart setup perfectly here -> time is koming | BEIJING BILL | investorshub | 08/17/2022 4:51:49 PM |
Hey whatever it takes to see it rise | retired early | investorshub | 05/27/2022 5:06:22 PM |
,,,,,,,Im out | THEMASTERS_SON | investorshub | 04/04/2022 6:56:50 PM |
3/22 Oragenics Initiates a Pivotal IND-Enabling Toxicology | unpathedhaunt | investorshub | 03/22/2022 3:00:14 PM |
KABOOM !! ve got movement!! | BEIJING BILL | investorshub | 03/03/2022 2:24:32 PM |
Looks like word is getting out. :) | retired early | investorshub | 02/25/2022 5:20:13 PM |
I agree. The buy consensus is at 83%.3 | retired early | investorshub | 01/04/2022 7:11:27 PM |
$HUGE insider buy | Nathans123 | investorshub | 01/04/2022 1:14:01 AM |
$OGEN HOD | TheFinalCD | investorshub | 12/20/2021 4:51:16 PM |
lets get this back over $1 | shurtha2000 | investorshub | 12/20/2021 3:50:52 PM |
Oragenics ($OGEN) Extends Collaboration with the National Research | alisher | investorshub | 12/20/2021 1:46:22 PM |
Oragenics Announces Positive COVID-19 Challenge Study Results | alisher | investorshub | 12/04/2021 10:48:57 PM |
News! | Renegade Rich | investorshub | 12/01/2021 4:59:31 PM |
ORAGENICS is really on a good way to | Mountainman5 | investorshub | 09/12/2021 12:27:53 PM |
Opps good call. I own both and posted | retired early | investorshub | 08/30/2021 2:01:26 PM |
How does that help $OGEN? | oakrock | investorshub | 08/26/2021 5:44:18 AM |
Qiagen has received emergency use authorization from the | retired early | investorshub | 08/06/2021 5:28:47 PM |
News, Short Squeeze, Breakout and More Instantly...
SARASOTA, Fla., June 27, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced it has completed a prototype of its automated intranasal device for use in concu...
SARASOTA, Fla., June 26, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced the closing of its public offering of 1,100,000 shares of its common stock ...